12:00 AM
 | 
Aug 26, 2010
 |  BC Innovations  |  Distillery Therapeutics

Indication: Cardiovascular disease

Indication Target/marker/pathway Summary Licensing status Publication and contact information
Cardiovascular disease
Hypertension Malonyl-CoA decarboxylase (MLYCD; MCD); pyruvate dehydrogenase kinase (PDK); 3-ketoacyl-CoA thiolase (ACAA2) A study in mice suggests...

Read the full 224 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Innovations

Article Purchase

$35 USD
More Info >